Literature DB >> 26080397

Nuclear matrix-associated protein SMAR1 regulates alternative splicing via HDAC6-mediated deacetylation of Sam68.

Kiran Kumar Nakka1, Nidhi Chaudhary2, Shruti Joshi2, Jyotsna Bhat3, Kulwant Singh4, Subhrangsu Chatterjee3, Renu Malhotra5, Abhijit De5, Manas Kumar Santra6, F Jeffrey Dilworth7, Samit Chattopadhyay8.   

Abstract

Pre-mRNA splicing is a complex regulatory nexus modulated by various trans-factors and their posttranslational modifications to create a dynamic transcriptome through alternative splicing. Signal-induced phosphorylation and dephosphorylation of trans-factors are known to regulate alternative splicing. However, the role of other posttranslational modifications, such as deacetylation/acetylation, methylation, and ubiquitination, that could modulate alternative splicing in either a signal-dependent or -independent manner remain enigmatic. Here, we demonstrate that Scaffold/matrix-associated region-binding protein 1 (SMAR1) negatively regulates alternative splicing through histone deacetylase 6 (HDAC6)-mediated deacetylation of RNA-binding protein Sam68 (Src-associated substrate during mitosis of 68 kDa). SMAR1 is enriched in nuclear splicing speckles and associates with the snRNAs that are involved in splice site recognition. ERK-MAPK pathway that regulates alternative splicing facilitates ERK-1/2-mediated phosphorylation of SMAR1 at threonines 345 and 360 and localizes SMAR1 to the cytoplasm, preventing its interaction with Sam68. We showed that endogenously, SMAR1 through HDAC6 maintains Sam68 in a deacetylated state. However, knockdown or ERK-mediated phosphorylation of SMAR1 releases the inhibitory SMAR1-HDAC6-Sam68 complex, facilitating Sam68 acetylation and alternative splicing. Furthermore, loss of heterozygosity at the Chr.16q24.3 locus in breast cancer cells, wherein the human homolog of SMAR1 (BANP) has been mapped, enhances Sam68 acetylation and CD44 variant exon inclusion. In addition, tail-vein injections in mice with human breast cancer MCF-7 cells depleted for SMAR1 showed increased CD44 variant exon inclusion and concomitant metastatic propensity, confirming the functional role of SMAR1 in regulation of alternative splicing. Thus, our results reveal the complex molecular mechanism underlying SMAR1-mediated signal-dependent and -independent regulation of alternative splicing via Sam68 deacetylation.

Entities:  

Keywords:  HDAC6; SMAR1; Sam68; alternative splicing; deacetylation

Mesh:

Substances:

Year:  2015        PMID: 26080397      PMCID: PMC4491761          DOI: 10.1073/pnas.1418603112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Alternative RNA splicing complexes containing the scaffold attachment factor SAFB2.

Authors:  Kate A Sergeant; Cyril F Bourgeois; Caroline Dalgliesh; Julian P Venables; James Stevenin; David J Elliott
Journal:  J Cell Sci       Date:  2007-01-02       Impact factor: 5.285

2.  SMAR1-derived P44 peptide retains its tumor suppressor function through modulation of p53.

Authors:  Archana Jalota-Badhwar; Ruchika Kaul-Ghanekar; Devraj Mogare; Ramanamurthy Boppana; Kishore M Paknikar; Samit Chattopadhyay
Journal:  J Biol Chem       Date:  2007-01-17       Impact factor: 5.157

Review 3.  Signals, pathways and splicing regulation.

Authors:  Matias Blaustein; Federico Pelisch; Anabella Srebrow
Journal:  Int J Biochem Cell Biol       Date:  2007-04-08       Impact factor: 5.085

Review 4.  Splicing, transcription, and chromatin: a ménage à trois.

Authors:  Eric Allemand; Eric Batsché; Christian Muchardt
Journal:  Curr Opin Genet Dev       Date:  2008-03-26       Impact factor: 5.578

5.  Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex.

Authors:  Shravanti Rampalli; L Pavithra; Altaf Bhatt; Tapas K Kundu; Samit Chattopadhyay
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

6.  Regulation of CD44 alternative splicing by SRm160 and its potential role in tumor cell invasion.

Authors:  Chonghui Cheng; Phillip A Sharp
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

7.  The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth.

Authors:  Heather R Christofk; Matthew G Vander Heiden; Marian H Harris; Arvind Ramanathan; Robert E Gerszten; Ru Wei; Mark D Fleming; Stuart L Schreiber; Lewis C Cantley
Journal:  Nature       Date:  2008-03-13       Impact factor: 49.962

Review 8.  Lysine acetylation: codified crosstalk with other posttranslational modifications.

Authors:  Xiang-Jiao Yang; Edward Seto
Journal:  Mol Cell       Date:  2008-08-22       Impact factor: 17.970

9.  p53 target gene SMAR1 is dysregulated in breast cancer: its role in cancer cell migration and invasion.

Authors:  Kamini Singh; Devraj Mogare; Ramprasad Obula Giridharagopalan; Rajinikanth Gogiraju; Gopal Pande; Samit Chattopadhyay
Journal:  PLoS One       Date:  2007-08-01       Impact factor: 3.240

10.  The RNA-binding protein Sam68 modulates the alternative splicing of Bcl-x.

Authors:  Maria Paola Paronetto; Tilman Achsel; Autumn Massiello; Charles E Chalfant; Claudio Sette
Journal:  J Cell Biol       Date:  2007-03-19       Impact factor: 10.539

View more
  22 in total

1.  Analysis of the interaction between host factor Sam68 and viral elements during foot-and-mouth disease virus infections.

Authors:  Devendra K Rai; Paul Lawrence; Anna Kloc; Elizabeth Schafer; Elizabeth Rieder
Journal:  Virol J       Date:  2015-12-23       Impact factor: 4.099

Review 2.  The RNA Splicing Response to DNA Damage.

Authors:  Lulzim Shkreta; Benoit Chabot
Journal:  Biomolecules       Date:  2015-10-29

Review 3.  Chromatin Remodeling Protein SMAR1 Is a Critical Regulator of T Helper Cell Differentiation and Inflammatory Diseases.

Authors:  Bhalchandra Mirlekar; Dipendra Gautam; Samit Chattopadhyay
Journal:  Front Immunol       Date:  2017-02-09       Impact factor: 7.561

4.  Cdc20 directs proteasome-mediated degradation of the tumor suppressor SMAR1 in higher grades of cancer through the anaphase promoting complex.

Authors:  Debasish Paul; Suvankar Ghorai; U S Dinesh; Praveenkumar Shetty; Samit Chattopadhyay; Manas Kumar Santra
Journal:  Cell Death Dis       Date:  2017-06-15       Impact factor: 8.469

Review 5.  Diversification of the muscle proteome through alternative splicing.

Authors:  Kiran Nakka; Claudia Ghigna; Davide Gabellini; F Jeffrey Dilworth
Journal:  Skelet Muscle       Date:  2018-03-06       Impact factor: 4.912

6.  HDAC6 Substrate Discovery Using Proteomics-Based Substrate Trapping: HDAC6 Deacetylates PRMT5 to Influence Methyltransferase Activity.

Authors:  Inosha D Gomes; Udana V Ariyaratne; Mary Kay H Pflum
Journal:  ACS Chem Biol       Date:  2021-07-27       Impact factor: 4.634

7.  Genome-wide association study of copy number variation with lung function identifies a novel signal of association near BANP for forced vital capacity.

Authors:  Nick Shrine; Martin D Tobin; Claudia Schurmann; María Soler Artigas; Jennie Hui; Terho Lehtimäki; Olli T Raitakari; Craig E Pennell; Qi Wei Ang; David P Strachan; Georg Homuth; Sven Gläser; Stephan B Felix; David M Evans; John Henderson; Raquel Granell; Lyle J Palmer; Jennifer Huffman; Caroline Hayward; Generation Scotland; Anders Malarstig; Bill Musk; Alan L James; Louise V Wain
Journal:  BMC Genet       Date:  2016-08-11       Impact factor: 2.797

8.  Alternative Splicing of Toll-Like Receptor 9 Transcript in Teleost Fish Grouper Is Regulated by NF-κB Signaling via Phosphorylation of the C-Terminal Domain of the RPB1 Subunit of RNA Polymerase II.

Authors:  Frank Fang-Yao Lee; Cho-Fat Hui; Tien-Hsien Chang; Pinwen Peter Chiou
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

9.  SMAR1 binds to T(C/G) repeat and inhibits tumor progression by regulating miR-371-373 cluster.

Authors:  Jinumary Mathai; Smriti P K Mittal; Aftab Alam; Payal Ranade; Devraj Mogare; Sonal Patel; Smita Saxena; Suvankar Ghorai; Abhijeet P Kulkarni; Samit Chattopadhyay
Journal:  Sci Rep       Date:  2016-09-27       Impact factor: 4.379

10.  SMAR1 inhibits Wnt/β-catenin signaling and prevents colorectal cancer progression.

Authors:  Nandaraj Taye; Aftab Alam; Suvankar Ghorai; Deya Ghosh Chatterji; Apoorva Parulekar; Devraj Mogare; Snahlata Singh; Pallabi Sengupta; Subhrangsu Chatterjee; Manoj Kumar Bhat; Manas Kumar Santra; Prabhakar Budha Salunkhe; Susan Kling Finston; Samit Chattopadhyay
Journal:  Oncotarget       Date:  2018-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.